6wan: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
Line 3: Line 3:
<StructureSection load='6wan' size='340' side='right'caption='[[6wan]], [[Resolution|resolution]] 2.40&Aring;' scene=''>
<StructureSection load='6wan' size='340' side='right'caption='[[6wan]], [[Resolution|resolution]] 2.40&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[6wan]] is a 12 chain structure with sequence from [http://en.wikipedia.org/wiki/Aciba Aciba]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6WAN OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6WAN FirstGlance]. <br>
<table><tr><td colspan='2'>[[6wan]] is a 12 chain structure with sequence from [https://en.wikipedia.org/wiki/Acinetobacter_baumannii Acinetobacter baumannii] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6WAN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6WAN FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.4&#8491;</td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HMPREF0023_0548 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=470 ACIBA])</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6wan FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wan OCA], [http://pdbe.org/6wan PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6wan RCSB], [http://www.ebi.ac.uk/pdbsum/6wan PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6wan ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6wan FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wan OCA], [https://pdbe.org/6wan PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6wan RCSB], [https://www.ebi.ac.uk/pdbsum/6wan PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6wan ProSAT]</span></td></tr>
</table>
</table>
== Function ==
[https://www.uniprot.org/uniprot/CAP4_ACIS2 CAP4_ACIS2] CBASS (cyclic oligonucleotide-based antiphage signaling system) provides immunity against bacteriophage. The CD-NTase protein synthesizes cyclic nucleotides in response to infection; these serve as specific second messenger signals. The signals activate a diverse range of effectors, leading to bacterial cell death and thus abortive phage infection. A type II-C(AAAA) CBASS system (PubMed:32839535).<ref>PMID:32839535</ref> <ref>PMID:32544385</ref>  Binds cyclic nucleotide second messengers (synthesized by CdnD, the cognate CD-NTase in the CBASS operon). Ligand binding activates it to endonucleolytically degrade dsDNA to approximately 6 bp length fragments, with a preference for 5'-C or 5'-G cleavage site. The minor product of CdnD is the activating nucleotide; also binds the major product (2',3',3'-cyclic AMP-AMP-AMP) but is not activated by it. Only binds DNA in the presence of ligand. Is not activated by c-di-AMP, c-di-GMP, 3'3'-cyclic GMP-AMP (3'3'-cGAMP) or 3',3',3'-cyclic AMP-AMP-GMP.<ref>PMID:32544385</ref>
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 21: Line 23:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Aciba]]
[[Category: Acinetobacter baumannii]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Antine, S P]]
[[Category: Synthetic construct]]
[[Category: Cabrera, V]]
[[Category: Antine SP]]
[[Category: Keszei, A F.A]]
[[Category: Cabrera V]]
[[Category: Kranzusch, P J]]
[[Category: Keszei AFA]]
[[Category: Lee, A S.Y]]
[[Category: Kranzusch PJ]]
[[Category: Lowey, B]]
[[Category: Lee ASY]]
[[Category: Mekalanos, J J]]
[[Category: Lowey B]]
[[Category: Morehouse, B R]]
[[Category: Mekalanos JJ]]
[[Category: Schwede, F]]
[[Category: Morehouse BR]]
[[Category: Shao, S]]
[[Category: Schwede F]]
[[Category: Whiteley, A T]]
[[Category: Shao S]]
[[Category: Carf]]
[[Category: Whiteley AT]]
[[Category: Duf4297]]
[[Category: Hydrolase]]
[[Category: Nuclease]]
[[Category: Phage immunity]]
[[Category: Saved]]